FDA Inspection 1274217 — Tissue Regenix, Inc.
The FDA completed an inspection of Tissue Regenix, Inc. on Jun 24, 2025 in Buford, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 24, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Buford, GA (United States)